The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Population-based outcome of stages IA-IIA resected gastric adenocarcinoma: Who should get adjuvant treatment?
Jason S. Gold
No relevant relationships to disclose
Riad H. Al Natour
No relevant relationships to disclose
Mandeep S. Saund
No relevant relationships to disclose
Charles H. Yoon
No relevant relationships to disclose
Ashish M. Sharma
No relevant relationships to disclose
Qin Huang
No relevant relationships to disclose
Valia A. Boosalis
No relevant relationships to disclose
Edward E. Whang
No relevant relationships to disclose